Dose-Dependent Suppression of Ovulation and Ovarian Activity by Elagolix in Healthy Premenopausal Women. Meeting Abstract

sustainable development goals

publication date

  • March 1, 2017

webpage

published in

start page

  • 140A

end page

  • 140A

volume

  • 24